Health In Tech Stock Analysis
| HIT Stock | 1.61 0.06 3.59% |
Health In Tech holds a debt-to-equity ratio of 1.14. At this time, Health In's Interest Debt Per Share is comparatively stable compared to the past year. Cash Flow To Debt Ratio is likely to gain to 9.95 in 2026, whereas Short and Long Term Debt Total is likely to drop slightly above 176.7 K in 2026. Health In's financial risk is the risk to Health In stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Health In's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Health In's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Health Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Health In's stakeholders.
For most companies, including Health In, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Health In Tech, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Health In's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Liabilities And Stockholders Equity is likely to gain to about 14.9 M in 2026, whereas Total Current Liabilities is likely to drop slightly above 1.8 M in 2026. Health In Tech is overvalued with Real Value of 1.55 and Hype Value of 1.51. The main objective of Health In stock analysis is to determine its intrinsic value, which is an estimate of what Health In Tech is worth, separate from its market price. There are two main types of Health In's stock analysis: fundamental analysis and technical analysis.
The Health In stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Health In is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Health Stock trading window is adjusted to America/New York timezone.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Health In Tech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. Health Stock Analysis Notes
About 70.0% of the company shares are held by company insiders. The company last dividend was issued on the September 28, 2011. Hitachi, Ltd. manufactures and sells electronic and electrical solutions primarily in Asia, North America, and Europe. To learn more about Health In Tech call Tim Johnson at 888 373 0333 or check out https://healthintech.com.Health In Quarterly Total Revenue |
|
Health In Tech Investment Alerts
| Health In Tech generated a negative expected return over the last 90 days | |
| Health In Tech has high historical volatility and very poor performance | |
| Health In Tech may become a speculative penny stock | |
| Health In Tech is unlikely to experience financial distress in the next 2 years | |
| Health In Tech has a strong financial position based on the latest SEC filings | |
| About 70.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Insider Trading |
Health Market Capitalization
The company currently falls under 'Micro-Cap' category with a total capitalization of 95.04 M.Health Profitablity
The company has Net Profit Margin of 0.05 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.06 %, which entails that for every 100 dollars of revenue, it generated $0.06 of operating income.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.05 | 0.10 | |
| Return On Capital Employed | 0.07 | 0.06 | |
| Return On Assets | 0.04 | 0.07 | |
| Return On Equity | 0.06 | 0.06 |
Management Efficiency
Health In Tech has Return on Asset of 0.0533 % which means that on every $100 spent on assets, it made $0.0533 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1194 %, implying that it generated $0.1194 on every 100 dollars invested. Health In's management efficiency ratios could be used to measure how well Health In manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Health In's Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.07 in 2026, whereas Return On Capital Employed is likely to drop 0.06 in 2026. Liabilities And Stockholders Equity is likely to gain to about 14.9 M in 2026, whereas Total Current Liabilities is likely to drop slightly above 1.8 M in 2026.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.18 | 0.19 | |
| Tangible Book Value Per Share | 0.12 | 0.13 | |
| Enterprise Value Over EBITDA | 210.11 | 199.61 | |
| Price Book Value Ratio | 31.38 | 29.81 | |
| Enterprise Value Multiple | 210.11 | 199.61 | |
| Price Fair Value | 31.38 | 29.81 | |
| Enterprise Value | 247.7 M | 219.9 M |
The operational strategies employed by Health In management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Technical Drivers
As of the 9th of January, Health In retains the risk adjusted performance of (0.06), and Market Risk Adjusted Performance of (0.71). Health In technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Health In Tech Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as Health In Tech price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
Health In Tech Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Health In insiders, such as employees or executives, is commonly permitted as long as it does not rely on Health In's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Health In insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Qian Linlin over a week ago Acquisition by Qian Linlin of 80000 shares of Health In subject to Rule 16b-3 | ||
Zain Hasan over a week ago Insider Trading | ||
Clarkson Michael David over two months ago Acquisition by Clarkson Michael David of 8000 shares of Health In subject to Rule 16b-3 | ||
Clarkson Michael David over two months ago Insider Trading | ||
Shrestha Sanjay K over three months ago Acquisition by Shrestha Sanjay K of 5730 shares of Health In at 3.49 subject to Rule 16b-3 | ||
Shrestha Sanjay K over three months ago Disposition of 65469 shares by Shrestha Sanjay K of Health In subject to Rule 16b-3 | ||
Qian Linlin over three months ago Acquisition by Qian Linlin of 80000 shares of Health In subject to Rule 16b-3 | ||
Umemezia Chike over six months ago Acquisition by Umemezia Chike of 128474 shares of Health In at 0.62 subject to Rule 16b-3 |
Health In Outstanding Bonds
Health In issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Health In Tech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Health bonds can be classified according to their maturity, which is the date when Health In Tech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| HEALTH CARE REIT Corp BondUS42217KAX46 | View | |
| HEALTH CARE REIT Corp BondUS42217KBB17 | View | |
| US42218SAF56 Corp BondUS42218SAF56 | View | |
| US42218SAH13 Corp BondUS42218SAH13 | View |
Health In Predictive Daily Indicators
Health In intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Health In stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Health In Forecast Models
Health In's time-series forecasting models are one of many Health In's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Health In's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Health In Bond Ratings
Health In Tech financial ratings play a critical role in determining how much Health In have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Health In's borrowing costs.| Piotroski F Score | 8 | Strong | View |
| Beneish M Score | (2.77) | Unlikely Manipulator | View |
Health In Tech Debt to Cash Allocation
Health In Tech has 206.69 K in debt with debt to equity (D/E) ratio of 1.14, which is OK given its current industry classification. Health In Tech has a current ratio of 1.15, demonstrating that it is not liquid enough and may have problems paying out its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Health to invest in growth at high rates of return.Health In Total Assets Over Time
Health In Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Health In uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Health In Debt Ratio | 1.12 |
Health In Corporate Bonds Issued
Health Short Long Term Debt Total
Short Long Term Debt Total |
|
About Health Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Health In prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Health shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Health In. By using and applying Health Stock analysis, traders can create a robust methodology for identifying Health entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 0.04 | 0.07 | |
| Operating Profit Margin | 0.05 | 0.07 | |
| Net Profit Margin | 0.03 | 0.05 | |
| Gross Profit Margin | 0.91 | 0.96 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Health In to your portfolios without increasing risk or reducing expected return.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Additional Tools for Health Stock Analysis
When running Health In's price analysis, check to measure Health In's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health In is operating at the current time. Most of Health In's value examination focuses on studying past and present price action to predict the probability of Health In's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health In's price. Additionally, you may evaluate how the addition of Health In to your portfolios can decrease your overall portfolio volatility.